US Patent 10265402 | Patents | Expiry | Expiration | Dates

NEURELIS INC

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

DIAZEPAM

Supporting Information : Click here to upload a PDF

US Patent Number

10265402

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2025-05-11

Patent Use Code

Delist Requested

Application Number

211635

Patent Use Description

Product Number

3

NEURELIS INC

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

DIAZEPAM

Supporting Information : Click here to upload a PDF

US Patent Number

10265402

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2025-05-11

Patent Use Code

Delist Requested

Application Number

211635

Patent Use Description

Product Number

1

NEURELIS INC

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

DIAZEPAM

Supporting Information : Click here to upload a PDF

US Patent Number

10265402

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2025-05-11

Patent Use Code

Delist Requested

Application Number

211635

Patent Use Description

Product Number

Find

Information, Expiry & Status of FDA Orange Book Patents covering 10265402

U.S. Patents

NEURELIS INC

DIAZEPAM

10265402

Y

2025-05-11

211635

3

NEURELIS INC

DIAZEPAM

10265402

Y

2025-05-11

211635

1

NEURELIS INC

DIAZEPAM

10265402

Y

2025-05-11

211635

2